Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

New phase III trial of loteprednol etabonate for allergic rhinitis

Aug. 21, 2003

Selective iNOS inhibitors show potential in the treatment of endotoxin-induced uveitis

Aug. 21, 2003

Phase IIIb results support use of diquafosol in dry eye

Aug. 20, 2003

AlphaCor introduction for cornea transplant patients who reject human tissue

Aug. 20, 2003

Santen seeks Japanese manufacturing approval for vernal keratoconjunctivitis treatment

Aug. 18, 2003

ISTA files second Vitrase NDA

Aug. 7, 2003

Squalamine improves visual outcomes in phase I/II wet AMD study

Aug. 6, 2003

Priority review for diquafosol tetrasodium NDA

Aug. 5, 2003

IGF-I peptides useful in ophthalmology and dermatology

Aug. 4, 2003

IOP-lowering agents prepared and tested by Alcon researchers

July 28, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...